Is a Blood Pressure Reading of 140/90 mmHg Considered Hypertension?

Yes, a blood pressure reading of 140/90 mmHg is classified as hypertension according to current international guidelines—including those from the American College of Cardiology (ACC) and the American Heart Association (AHA), as well as the European Society of Cardiology (ESC) and the World Health Organization (WHO).

This value represents systolic pressure (140 mmHg) and diastolic pressure (90 mmHg). Under the ACC/AHA 2017 guidelines, hypertension is defined as a consistent systolic blood pressure of 130 mmHg or higher, or a diastolic blood pressure of 80 mmHg or higher—making 140/90 mmHg indicative of Stage 2 hypertension. The ESC 2023 guidelines maintain a slightly higher threshold for diagnosis in clinical settings (≥140/90 mmHg), but still categorize this reading as unequivocally hypertensive.

It is important to emphasize that a single elevated reading does not confirm a diagnosis. Hypertension requires confirmation through repeated measurements on at least two separate occasions, ideally using validated devices and following standardized protocols—such as seated rest for five minutes, proper cuff sizing, and avoidance of caffeine, smoking, or exercise for 30 minutes prior to measurement. Ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) may be recommended to rule out white-coat hypertension or masked hypertension.

Sustained blood pressure at or above 140/90 mmHg significantly increases the risk of cardiovascular morbidity and mortality, including ischemic heart disease, stroke, chronic kidney disease, and heart failure. Clinical evaluation should therefore include assessment of modifiable risk factors (e.g., dyslipidemia, diabetes, smoking, obesity), target organ damage (e.g., left ventricular hypertrophy, retinopathy, reduced estimated glomerular filtration rate), and secondary causes—particularly in younger patients or those with abrupt onset or resistant hypertension.

Management typically begins with lifestyle modifications: sodium restriction (<1,500–2,300 mg/day), adherence to the DASH or Mediterranean diet, regular aerobic exercise, weight optimization, moderation of alcohol intake, and tobacco cessation. Pharmacologic therapy is generally indicated for individuals with Stage 2 hypertension, especially if cardiovascular risk is elevated or evidence of end-organ damage is present. First-line agents commonly include ACE inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, or thiazide-like diuretics—selected based on age, race, comorbidities, and tolerability.